Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects

Chowdhury, G M I, Zhang, J, Thomas, M, Banasr, M, Ma, X, Pittman, B, Bristow, L, Schaeffer, E +4 more·2017·Molecular Psychiatry

DOI 10.1038/mp.2016.34

Cited by (198)

Items 101–198 of 198

The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice
Karolina Podkowa, Andrzej Pilc, Adrian Podkowa, Kinga Sałat, Marcin Marciniak, Agnieszka Pałucha-Poniewiera · 2018 · Neuropharmacology
Facilitation of dopamine‐dependent long‐term potentiation in the medial prefrontal cortex of male rats follows the behavioral effects of stress
Jacopo Lamanna, Francesco Isotti, Mattia Ferro, Gabriella Racchetti, Lavinia Anchora, Daniele Rucco, Antonio Malgaroli · 2020 · Journal of Neuroscience Research
The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice
Hanjie Yu, Mengmeng Li, Xinbei Shen, Dan Lv, Xin Sun, Jinting Wang, Xinmei Gu, Jingning Hu, Chuang Wang · 2017 · The International Journal of Neuropsychopharmacology
GSK ‐3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput
Carlos A. Zarate, Rodrigo Machado‐Vieira · 2016 · Bipolar Disorders
Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders
Anthony G. Phillips, Mark A. Geyer, Trevor William Robbins · 2018 · Biological Psychiatry
Pharmacological Characterization of the Novel and Selective α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator BNC375
Xiaohai Wang, Christopher Daley, Vanita Gakhar, Henry S. Lange, Joshua D. Vardigan, Michelle S. Pearson, Xiaoping Zhou, Lee Warren, Corin O. Miller, Michelle Belden et al. · 2020 · Journal of Pharmacology and Experimental Therapeutics
M2-AChR Mediates Rapid Antidepressant Effects of Scopolamine Through Activating the mTORC1-BDNF Signaling Pathway in the Medial Prefrontal Cortex
Shuang Liu, Dandan Shi, Zuoli Sun, Yi He, Jian Yang, Gang Wang · 2021 · Frontiers in Psychiatry
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
Jules Mitchell, Daniel Francis Hermens, Maxwell R. Bennett, Adem Can, Jim Lagopoulos · 2023 · CNS Drugs
Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine
Daniele Cavaleri, Ilaria Riboldi, Cristina Crocamo, Giuseppe Paglia, Giuseppe Carrà, Francesco Bartoli · 2024 · Neuroscience Letters
Rapid anti‐depressant‐like effects of ketamine and other candidates: Molecular and cellular mechanisms
Fan Peng, Jie Fan, Tongtong Ge, Qian Qian Liu, Bing Jin Li · 2020 · Cell Proliferation
AMPAkine CX516 alleviated chronic ethanol exposure-induced neurodegeneration and depressive-like behavior in mice
Hui Yao, Dalin Zhang, Hao Yu, Hui Shen, Xinze Lan, Hao Liu, Xiaohuan Chen, Xu Wu, Guohua Zhang, Xiaolong Wang · 2022 · Toxicology and Applied Pharmacology
Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect
Matjaž Stenovec · 2021 · Life
Ketamine: A Review for Clinicians
Gerard Sanacora, Rachel R. Katz · 2018 · FOCUS The Journal of Lifelong Learning in Psychiatry
Rapid‐acting antidepressants and the regulation of TrkB neurotrophic signalling—Insights from ketamine, nitrous oxide, seizures and anaesthesia
Samuel Kohtala, Tomi Rantamäki · 2021 · Basic & Clinical Pharmacology & Toxicology
Healthy Aging in Menopause: Prevention of Cognitive Decline, Depression and Dementia through Physical Exercise
Carmen Guerrero-González, Cristina Cueto‐Ureña, Vanesa Cantón-Habas, Marı́a Jesús Ramı́rez-Expósito, José Manuel Martı́nez-Martos · 2024 · Physiologia
The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?
Marcos Emílio Frizzo · 2019 · Current Therapeutic Research
Predicting a Potential Link to Antidepressant Effect: Neuroprotection of Zhi-zi-chi Decoction on Glutamate-induced Cytotoxicity in PC12 Cells
Yin Zhang⋆, Yusha Luo, Dongqi Zhang, Bo Pang, Jun Wen, Tingting Zhou · 2021 · Frontiers in Pharmacology
Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity
Kyle A. Brown, Musa Iyiola Ajibola, Todd D. Gould · 2025 · Neuropsychopharmacology
Neuronal glutamatergic changes and peripheral markers of cytoskeleton dynamics change synchronically 24 h after sub-anaesthetic dose of ketamine in healthy subjects
Lejla Čolić, Conor McDonnell, Meng Li, Marie Woelfer, Thomas Liebe, Moritz Kretzschmar, Oliver Speck, Björn Hendrik Schott, Massimiliano Bianchi, Martin Walter · 2018 · Behavioural Brain Research
CYP 450 enzymes influence (R,S)-ketamine brain delivery and its antidepressant activity
Thi Mai Loan Nguyen, Josephine Cecelia McGowan, Alain Michel Gardier · 2021 · Neuropharmacology
Stress, mental disorder and ketamine as a novel, rapid acting treatment
Megan Dutton, Adem Can, Jim Lagopoulos, Daniel Francis Hermens · 2022 · European Neuropsychopharmacology
A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine
Ola Sobhy A. Elmeseiny, Heidi Kaastrup Müller · 2024 · Pharmacological Research
Promising new pharmacological targets for depression: The search for efficacy
Lucila Emiko Tsugiyama, Ruan Carlos Macêdo de Moraes, Yaslle Andrade Cavalcante Moraes, José Fernando de Oliveira · 2023 · Drug Discovery Today
Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression
Asch, Ruth H., Abdallah, Chadi G., Carson, Richard E., Esterlis, Irina · 2025 · Neuropsychopharmacology
The NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action
Vestring, Stefan, Veleanu, Maxime, Perez, Marina Conde, Schuberth, Louise E., Bronnec, Martin, Li, Anna, Würz, Lovis M., Erdogdu, Fatih, Stocker, Julia, Moos, Johanna et al. · 2025 · Nature Communications
The influence of ketamine’s repeated treatment on brain topology does not suggest an antidepressant efficacy
Natalia Gass, Robert Becker, Jonathan Reinwald, Alejandro Cosa‐Linan, Markus Sack, Wolfgang Weber‐Fahr, Barbara Vollmayr, Alexander Sartorius · 2020 · Translational Psychiatry
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
Matteo Marcatili, Carlo Sala, Antonios Dakanalis, Fabrizia Colmegna, Armando D’Agostino, Orsola Gambini, Bernardo Maria Dell’Osso, Beatrice Benatti, Luciano Conti, Massimo Clerici · 2020 · Therapeutic Advances in Psychopharmacology
Rapid antidepressant effect of single-bout exercise is mediated by adiponectin-induced APPL1 nucleus translocation in anterior cingulate cortex
Tong Cheng, Douglas Affonso Formolo, Jiasui Yu, Yunxiao Zhong, Zonghao Ma, Akhlaq Hussain, Formolo Natalia Paludo Silveira, Li Zhang, Kenneth K.Y. Cheng, Georg S. Kranz et al. · 2025 · Molecular Psychiatry
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
Anna Onisiforou, Polymnia Georgiou, Panos Zanos · 2023 · Pharmacology Biochemistry and Behavior
Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics
Marina Kojic, Johan Saelens, Bashkim Kadriu, Carlos A. Zarate, Christoph Kraus · 2022 · Current topics in behavioral neurosciences
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors
Max E. Joffe, Chiaki I. Santiago, Sheryl Anne D. Vermudez, Nicole M. Fisher, Shalini Dogra, Colleen Marie Niswender, Peter Jeffrey Conn · 2021 · Neuropsychopharmacology
Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in mice
Bartłomiej Pochwat, Paulina Misztak, Julia Masternak, Ewa Bączyńska, Krystian Bijata, Matylda Roszkowska, Monika Bijata, Jakub Włodarczyk, Małgorzata Szafarz, Elżbieta Wyska et al. · 2022 · Frontiers in Pharmacology
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
Hanbo Yao, Xiaodong Wang, Jiaxin Chi, Haorong Chen, Yilin Liu, Yang Jiayi, Jiaqi Yu, Yongdui Ruan, Xufu Xiang, Jiang Pi et al. · 2024 · Molecules
Altered GABAergic Function, Cortical Microcircuitry, and Information Processing in Depression
Dwight F. Newton, Corey Fee, Yuliya S. Nikolova, Etienne L. Sibille · 2019 · Elsevier eBooks
Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder
Matti Gärtner, Mischa de Rover, Lena Václavů, Milan Scheidegger, Matthias J.P. van Osch, Simone Grimm · 2022 · The World Journal of Biological Psychiatry
HCN channels: New targets for the design of an antidepressant with rapid effects
Pan Luo, Guofang He, Dong Liu · 2018 · Journal of Affective Disorders
A Meta‐Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder
Shiwan Tao, Renhao Deng, Menghan Wei, Yunqi Huang, Huan Sun, Shuhan Yang, Shen Li, Chutian Xiao, Mingli Li · 2025 · Depression and Anxiety
Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential
Qianting Deng, Emily Parker, Chongyun Wu, Ling Zhu, Timon Cheng‐Yi Liu, Rui Duan, Luodan Yang · 2024 · Aging and Disease
Positive Allosteric Modulation of AMPAR by PF-4778574 Produced Rapid Onset Antidepressant Actions in Mice
Mengxin Shen, Dan Lv, Shuting Li, Yanhua Zhang, Zhen Wang, Chiyu Zhao, Xuejie Chen, Chuang Wang · 2018 · Cerebral Cortex
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats
Haiying Tang, Daniel W. Kukral, Yu-Wen Li, Matthew P. Fronheiser, Harold J. Malone, Adrienne Pena, Rick L. Pieschl, Kurex Sidik, Gabriel Tobon, Patrick L Chow et al. · 2018 · Journal of Psychopharmacology
A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant Response
Francis Rodriguez Bambico, Zhuoliang Li, Meaghan C. Creed, Danilo De Gregorio, Mustansir Diwan, Jessica L. Li, Sean McNeill, Gabriella Gobbi, Roger Raymond, José N. Nóbrega · 2019 · Cerebral Cortex
Psychoactive substances for the treatment of neuropsychiatric disorders
Zifan Zhen, Xueqiang Sun, Shiying Yuan, Jiancheng Zhang · 2024 · Asian Journal of Psychiatry
Cognitive and psychotic effects of ketamine “short- vs. long-term” therapy in a rat model of depression: Hippocampal TrkB/Akt/GSK-3β/mTOR/autophagy trajectories
Salehi Aref, Mohamed Z. Habib, Dalia Eid, Eman Hamdy Badr Eltantawy, Mohamed Taeimah, Fatma E. Hassan, Dina Aly El‐Gabry, Heba Hamed ElShahawi, Magda I. Mohamad, Ahmed M. Abdel-Tawab et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology
Yinxin Wang, Jiangang Xu, Xinyu Zhou, Lu Che, Minghan Qiu, Yang Liu, Ming Gao, Zhen Yang · 2025 · Advanced Science
Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial
Matti Gärtner, Anne Weigand, Marvin Sören Meiering, David Weigner, Luisa Carstens, Christian Keicher, Rita Hertrampf, Christian F. Beckmann, Maarten Mennes, Andreas Wunder et al. · 2023 · Neuropsychopharmacology
Glutamate Chemical Exchange Saturation Transfer ( GluCEST ) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model
Hao Li, Xunrong Luo, Kai Qi, Yijie Lv, Junnan Kan, Changfeng Yang, Xiaoqian Lin, Jin Tao, Wei Zhang, Yan Liu et al. · 2023 · Journal of Magnetic Resonance Imaging
The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders
2023 · International Review of Neurobiology
The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
Dongsun Park, Gwangho Lee, Won-Gyu Lee, B.S. Kim, Yoonji Lee, Ji‐Woon Kim · 2025 · Molecular Psychiatry
mGlu2/3 receptor as a novel target for rapid acting antidepressants
Shigeyuki Chaki · 2020 · Advances in pharmacology
Role of FMRP in rapid antidepressant effects and synapse regulation
Chelcie F. Heaney, Sanjeev V. Namjoshi, Ayse Uneri, Eva C. Bach, Jeffrey L. Weiner, Kimberly F. Raab‐Graham · 2021 · Molecular Psychiatry
Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models
María Camila Acero-Castillo, Mariana B.M. Correia, Fábio Viegas Caixeta, V. Motta, M. Barros, Rafael Souto Maior · 2024 · Neuropharmacology
Intermittent fasting produces antidepressant-like effects by modulating dopamine D1 receptors in the medial prefrontal cortex
Jingjing Piao, Hongyu Chen, Xinmiao Piao, Ziqian Cheng, Fangyi Zhao, Ranji Cui, Bingjin Li · 2025 · Neurobiology of Disease
Ketamina, un nuevo agente terapéutico para la depresión
Rodrigo Pérez‐Esparza, Luis Fabián Kobayashi-Romero, Ana María García Mendoza, Reyna Lamas-Aguilar, Melissa Vargas Sosa, Melissa Encarnación-Martínez, Luz Andrea González-Manríquez, Silvia Alejandra Eternod-Rodríguez, Fernanda Maltos-Gómez, Karen Marisel Vargas-Valencia et al. · 2020 · Revista de la Facultad de Medicina UNAM
Prefrontal contributions to mental resilience: Lessons from rodent studies of stress and antidepressant actions.
Ryota Shinohara, T. Furuyashiki · 2022 · Neurosciences research
Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons
Francisco Borja Belloch, María Cortés-Erice, Étienne Herzog, Xiao Min Zhang, Teresa Diaz-Perdigón, Elena Puerta, Rosa María Tordera · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Esketamine alleviates depressive-like behavior in mice via modulation of the microbiota-gut-brain axis and amino acid metabolism
Xue Gong, ZengYan Lai, Lei Li, Li Fan, Yikun Ren, Qi Zhong, Qiang Mao · 2025 · BMC Microbiology
Preventive effects of the AMPA receptor potentiator LY450108 in an LPS-induced depressive mouse model
Hui Yao, Wenting Guo, Long-Long Suo, Guoliang Li, Yun-Sheng Wang, Yuanyuan Chen, Yingui Sun, Runtao Ding · 2022 · Behavioural Brain Research
Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
Madison N. Irwin, Amy VandenBerg · 2021 · Mental Health Clinician
The role of ketamine in major depressive disorders: Effects on parvalbumin-positive interneurons in hippocampus
Iker Barrutieta-Arberas, Naiara Ortuzar, Andrea Vaquero-Rodríguez, Marina Picó-Gallardo, Harkaitz Bengoetxea, MA Guevara, P.A. Gargiulo, José Vicente Lafuente · 2023 · Experimental Biology and Medicine
Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine
Chadi G. Abdallah, Graeme F. Mason · 2021 · Neuropsychopharmacology
Reproducibility of the Determination of 13C‐Labeling of Glutamate and Glutamine in the Human Brain Using selPOCE‐MRS at 7 T Upon [U‐13C]–Labeled Glucose Infusion
Narjes Ahmadian, Sarah Jacobs, Mark W. J. M. Gosselink, Wybe J. M. van der Kemp, Hans M. Hoogduin, Anastasia Coppoli, Graeme F. Mason, Robin A. de Graaf, Helia Norouzizadeh, Chantal Mahon et al. · 2025 · NMR in Biomedicine
Pharmacotherapy for Cocaine Use Disorders
Boris B. Quednow, Etna Engeli, Marcus Herdener · 2022 · Springer eBooks
4-F-PCP, a Novel PCP Analog Ameliorates the Depressive-Like Behavior of Chronic Social Defeat Stress Mice via NMDA Receptor Antagonism
D. Ortiz, Mikyung Kim, Hyun Jun Lee, Chrislean Jun Botanas, R. J. Custodio, L. Sayson, Nicole Bon Campomayor, Chaeyeon Lee, Yong Sup Lee, J. Cheong et al. · 2023 · Biomolecules & Therapeutics
La kétamine : un neuropsychotrope au mécanisme d’action innovant
Jean‐Philippe Guilloux, Thi Mai Loan Nguyen, Alain Michel Gardier · 2023 · Biologie Aujourd hui
Searching for ketamine's antidepressant mechanisms: From synaptic plasticity to dentate gyrus cell proliferation
Tomi Rantamäki · 2019 · Acta Physiologica
Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model
Lace Marie Riggs, Sage Aronson, Ta-Chung M. Mou, Edna F. R. Pereira, Scott M. Thompson, Todd D. Gould · 2025 · Cell Reports
Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression
Qingmei Li, Shuming Liu, Bangyong Qin, Xingfeng Liu · 2025 · Neuropsychiatric Disease and Treatment
Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality
Zack Shan, Adem Can, Abdalla Z. Mohamed, Megan Dutton, Daniel Francis Hermens, Vince D. Calhoun, Leanne Maree Williams, Maxwell R. Bennett, Jim Lagopoulos · 2024 · European Archives of Psychiatry and Clinical Neuroscience
Licit use of illicit drugs for treating depression: the pill and the process
Alejandro Torrado Pacheco, Bita Moghaddam · 2024 · Journal of Clinical Investigation
Updates on Preclinical and Translational Neuroscience of Mood Disorders
Nicholas Mischel, Michael D. Kritzer, Ashwin A. Patkar, Prakash S. Masand, Steven T. Szabo · 2019 · Journal of Clinical Psychopharmacology
Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice
Lei Ming Guo, Shuzhuo Wang, Haihua Tian, Mengyuan Shang, Jia Xu, Chuang Wang · 2023 · Cerebral Cortex
Differential effects of ketamine enantiomers on EEG parameters including the gamma‐delta shift phenomenon
Szabolcs Koncz, Dóra Pothorszki, Noémi Papp, Donát Pál, György Bagdy · 2026 · British Journal of Pharmacology
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, Frederico Guilherme Graeff, Antônio Lúcio Teixeira · 2025 · Expert Opinion on Drug Discovery
Rapid‐Onset Therapeutic Effects of Delta Opioid Receptor Agonists on Depression‐Like Behaviors Induced by Chronic Social Defeat Stress
Akihisa Tokuda, Yasuyuki Nagumo, Keita Kajino, Keita Iio, Katsuyasu Sakurai, Seiya Mizuno, Akiyoshi Saitoh, Tsuyoshi Saitoh, Hiroshi Nagase · 2025 · Neuropsychopharmacology Reports
(2R,6R)-Hydroxynorketamine as a novel antidepressant and its role in the antidepressant actions of (R,S)-ketamine
Shigeyuki Chaki, Junichi Yamaguchi · 2021 · Elsevier eBooks
The association between amygdalar volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with the following open-label study
Kengo Yonezawa, Shinichiro Nakajima, Nobuaki Hondo, Yohei Ohtani, Kie Nomoto‐Takahashi, Taisuke Yatomi, Sota Tomiyama, Nobuhiro Nagai, Keisuke Kusudo, Koki Takahashi et al. · 2025 · Journal of Psychiatric Research
Multimodal rapid anti-depression: Esketamine combined with dexmedetomidine patient-controlled sleep for treatment-resistant depression — A retrospective study
Yao-Zu Li, Cai-Qun Zhao, Mu-Yan Zuo, Ruo-Guo Wang, John P. Williams, Jiun-Ming An · 2026 · Journal of Affective Disorders
Pharmacotherapy for Cocaine Use Disorders
Boris B. Quednow, Etna Engeli, Marcus Herdener · 2021 · Springer eBooks
Ketamine/esketamine for treatment-resistant depression
Sina Nikayin, Gerard Sanacora · 2022 · Elsevier eBooks
Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies
Gretchen Hermes, Gerard Sanacora · 2016 · Springer eBooks
Neurophysiologic Advance in Depressive Disorder
Lin Xu, Rongrong Mao · 2019 · Advances in experimental medicine and biology
The Search for Rapid Acting Antidepressants: Research Synthesis and Perspectives
Gerard Sanacora, Brandon M. Kitay, Samuel T. Wilkinson · 2019 · Elsevier eBooks
Characterization of the Wistar-Kyoto rat model of depression in the context of hippocampal synaptic plasticity and ketamine’s antidepressant properties
Lily R. Aleksandrova · 2019 · cIRcle (University of British Columbia)
Ketamine's potential mechanism of action for rapid antidepressive effects – a focus on neuroplasticity
Melody J.Y. Kang · 2020 · Elsevier eBooks
Rapid-Acting Antidepressant Effect of Ketamine and Its Clinical Application
Yong‐Ku Kim, Cheolmin Shin · 2018 · 신경정신의학
Astrocytes : role in genesis of psychical depression and action of the antidepressant drugs
Eduard Arushanyan · 2021 · Medical news of the North Caucasus
Contribution des jeunes neurones dans les neurotransmissions dans l’hippocampe après un traitement chronique avec la fluoxétine
Julie Doan · 2020
Опыт хирургического лечения расслаивающих аневризм восходящего отдела, дуги и нисходящего отдела грудной аорты
А. П. Шкет, В. В. Шумовец, Sergey V. Spiridonov, Шестакова Лиана Геннадьевна, Крачак Дмитрий Иосифович, Коржова Анна Викторовна, В. А. Токунов, Островский Юрий Петрович, A. A. Komarovskii, В. О. Одинцов et al. · 2013 · Medical Almanac
Faculty Opinions recommendation of Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment.
Hanns Möhler · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Editor's evaluation: Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Helen E. Scharfman · 2023 · eLife
Synaptic fidelity for drug development: is it time to move beyond glutamate release and receptors?
Chadi G. Abdallah, Amanda J. F. Tamman · 2024 · Expert Opinion on Therapeutic Targets
Effects of ketamine pretreatment on tetrabenazine-induced motivational impairments in male rats performing an effort-based decision-making task
Yukiko Yamamoto, Masato Nakashima, Kazunori Suzuki · 2025 · Heliyon
Ketamine’s Multifaceted Neuropharmacological and Neurobiological Actions
Samuel Kohtala, Iina Annala · 2025 · Neuromethods
Dynamic Processes Induced by Ketamine and Their Potential for Augmented Treatment Strategies in Neuropsychiatric Disorders
Meng Li, Zümrüt Duygu Şen, Lena Vera Danyeli, Nooshin Javaheripour, Martin Walter · 2025 · Neuromethods
Ketamine strengthens synaptic inputs to the dorsal raphé to boost serotonergic activity: pivotal for rapid antidepressant-like effects
Soukaina Es-Safi, Céline Bourcier‐Lucas, Erika Abrial, Adeline Cathala, Thierry Lesté-Lasserre, Philippe De Deurwaerdère, Jean‐Michel Revest, Jean Mazella, Nasser Haddjeri, Guillaume Lucas · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Exploring the molecular determinants of behavioral changes induced by ketamine at the nanoscale
Floriane Uyttersprot · 2024
Relationships of oxidative stress, inflammation and gut microbiota with cognitive impairment in first-episode major depressive disorders: a pilot study in China
Hehua Li, Baoyuan Zhu, Y L Huang, Shuhao Chen, Ziyun Zhang, Jingping Wu, Fengchun Wu, Kai Wu, Yuping Ning · 2026 · Frontiers in Microbiology
Network Pharmacology Reveals the Potential Mechanism of Ketamine in Improving Cognitive Impairment in Patients With Depression
Lei Yang, Qiuyu Zhang, Ying Zhang, Kaifang Yao, Ximing Chen, Hongjun Tian, Chuanjun Zhuo · 2026 · ALPHA PSYCHIATRY